Nodenza Venture Partners I, L.P.
Open, writing first checksEmerging manager
Open: first sale Apr 2024, per Form D (fund age approximates vintage)
- Vintage
- 2024
- Fund size
- $5.3M (Form D)
- Stages
- Not stated
- Sectors
- Biotech, Medical devices
- Regions
- Not stated
01 · Thesis
Nodenza seeks and invests in disruptive life sciences technologies and therapies with the potential to deliver exceptional benefits to patients. It invests at the clinical and product launch value inflection points of the life sciences value chain.Inferred from the firm's website
02 · Initial check
$53K to $88K (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Ross Morton
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideNodenza is focused on seeking and investing in disruptive technologies and therapies with the potential to deliver exceptional benefits to patients.
Nodenza is focused on seeking and investing in disruptive technologies and therapies with the potential to deliver exceptional benefits to patients.
https://nodenza.com/
06 · Sources
Last verified: Oct 28, 2026